These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8481419)

  • 1. Antitrust laws and the business of insurance.
    Berrey BH
    Va Med Q; 1993; 120(2):95-7. PubMed ID: 8481419
    [No Abstract]   [Full Text] [Related]  

  • 2. Health insurance industry shouldn't be exempt from antitrust laws.
    Goldberg LG; Greenberg W
    Healthspan; 1991 May; 8(5):3-9. PubMed ID: 10111989
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitrust enforcers cast a wary eye on health care--AMA admonition: pay attention to health plans!
    Freeman J
    Iowa Med; 2002; 92(6):26-7. PubMed ID: 12520621
    [No Abstract]   [Full Text] [Related]  

  • 4. Providers weigh Varney exit. Focus on antitrust laws made 'companies take notice'.
    Carlson J
    Mod Healthc; 2011 Jul; 41(28):12-3. PubMed ID: 21853589
    [No Abstract]   [Full Text] [Related]  

  • 5. Under a watchful eye. Insurers put on notice regarding antitrust concerns.
    Blesch G
    Mod Healthc; 2010 May; 40(22):14. PubMed ID: 20540199
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurance restrictions on provider risk assumption.
    Gordon D
    Benders Health Care Law Mon; 1997 Mar; ():4-11. PubMed ID: 10166831
    [No Abstract]   [Full Text] [Related]  

  • 7. Night landings on an aircraft carrier: hospital mergers and antitrust law.
    Greaney TL
    Am J Law Med; 1997; 23(2-3):191-220. PubMed ID: 9262755
    [No Abstract]   [Full Text] [Related]  

  • 8. Oligopsony, health insurance and antitrust.
    Hilsenrath PE; Destigter M
    Med Group Manage J; 1996; 43(2):52-8. PubMed ID: 10155946
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating antitrust risk in joint provider negotiations with payors.
    Leonard EJ
    Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feds widen probe. 'Most-favored nation' clauses draw more scrutiny.
    Evans M
    Mod Healthc; 2011 Apr; 41(14):8-9. PubMed ID: 21553426
    [No Abstract]   [Full Text] [Related]  

  • 11. Monopoly, monopsony, and market definition: an antitrust perspective on market concentration among health insurers.
    Hyman DA; Kovacic WE
    Health Aff (Millwood); 2004; 23(6):25-8. PubMed ID: 15537581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radial keratotomy on trial: new surgical procedures and the antitrust laws. Part 2.
    Duffey WS
    Refract Corneal Surg; 1989; 5(1):27-32. PubMed ID: 2488777
    [No Abstract]   [Full Text] [Related]  

  • 13. Entering a new decade.
    Vigna EJ
    Northwest Dent; 2010; 89(1):8-10. PubMed ID: 20344954
    [No Abstract]   [Full Text] [Related]  

  • 14. Say uncle. FTC fights to control hospital mergers.
    Neil R
    Mater Manag Health Care; 2003 Apr; 12(4):16-9. PubMed ID: 12854202
    [No Abstract]   [Full Text] [Related]  

  • 15. Do over in Pennsylvania. Ruling allows West Penn to proceed with lawsuit.
    Evans M
    Mod Healthc; 2010 Dec; 40(49):16. PubMed ID: 21249743
    [No Abstract]   [Full Text] [Related]  

  • 16. Legislation would shield PPOs from antitrust laws.
    Thompson MJ
    Mod Healthc; 1984 Aug; 14(10):158. PubMed ID: 10267487
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of preferred provider organizations and its antitrust implications.
    Maram BS
    J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care reform: summary of the Clinton administration's health reform plan: American Health Security Act of 1993.
    Baker N
    J Health Hosp Law; 1993 Oct; 26(10):289-95. PubMed ID: 10136101
    [No Abstract]   [Full Text] [Related]  

  • 19. Recipe for reform?
    Serafini MW
    Natl J (Wash); 1995 Mar; 27(9):546-9. PubMed ID: 10140851
    [No Abstract]   [Full Text] [Related]  

  • 20. Dems target insurer antitrust...as industry, experts give ho-hum response.
    Vesely R
    Mod Healthc; 2009 Oct; 39(43):10-1. PubMed ID: 19972650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.